Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
30.06
-0.54 (-1.76%)
At close: Feb 11, 2026, 4:00 PM EST
30.23
+0.17 (0.58%)
After-hours: Feb 11, 2026, 6:50 PM EST
Genmab Market Cap
Genmab has a market cap or net worth of $18.41 billion as of February 11, 2026. Its market cap has increased by 33.78% in one year.
Market Cap
18.41B
Enterprise Value
15.11B
1-Year Change
33.78%
Ranking
Category
Stock Price
$30.06
Market Cap Chart
Since April 23, 2012, Genmab's market cap has increased from $420.50M to $18.41B, an increase of 4,279.04%. That is a compound annual growth rate of 31.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 19.65B | -0.65% |
| Dec 31, 2025 | 19.78B | 43.19% |
| Dec 31, 2024 | 13.81B | -34.35% |
| Dec 29, 2023 | 21.04B | -24.60% |
| Dec 30, 2022 | 27.90B | 7.47% |
| Dec 31, 2021 | 25.96B | -1.89% |
| Dec 31, 2020 | 26.46B | 84.27% |
| Dec 31, 2019 | 14.36B | 35.31% |
| Dec 31, 2018 | 10.61B | -0.44% |
| Dec 29, 2017 | 10.66B | -0.04% |
| Dec 30, 2016 | 10.66B | 23.74% |
| Dec 31, 2015 | 8.62B | 128.70% |
| Dec 31, 2014 | 3.77B | 49.72% |
| Dec 31, 2013 | 2.52B | 179.56% |
| Dec 31, 2012 | 900.30M | 114.10% |
| Apr 23, 2012 | 420.50M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioNTech SE | 26.75B |
| Royalty Pharma | 25.77B |
| Incyte | 21.28B |
| Revolution Medicines | 18.85B |
| Roivant Sciences | 18.48B |
| Moderna | 16.02B |
| Ionis Pharmaceuticals | 14.01B |
| Ascendis Pharma | 13.64B |